BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer — Stella

Recruiting

Back to Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Illinois, Chicago, Illinois

Key details

Phase

Safety & dosing

Sponsor

University of Illinois at Chicago

Enrollment target

~25 participants

Started

November 2023

Primary completion

September 2034

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov